|
|||||
|
|
One-year and long-term molecular response to nilotinib and dasatinib for newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison |
|
| Authors: | James E. Signorovitch Keith A. Betts William M. Reichmann Darren Thomason Phil Galebach Eric Q. Wu |
| Affiliation: | Analysis Group Inc., Boston, MA, USA |
| Abstract: | |
| Keywords: | Chronic myeloid leukemia Dasatinib Indirect comparison Long-term molecular response Nilotinib |